mGluR5 modulators

Details for Australian Patent Application No. 2007303889 (hide)

Owner AstraZeneca AB

Inventors Dove, Peter; Stefanac, Tomislav; Slassi, Abdelmalik; Isaac, Methvin; Edwards, Louise; Xin, Tao

Agent Freehills

Pub. Number AU-B-2007303889

PCT Pub. Number WO2008/041075

Priority 60/828,325 05.10.06 US

Filing date 25 September 2007

Wipo publication date 10 April 2008

Acceptance publication date 24 February 2011

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/42 (2006.01) - Oxazoles

A61P 23/00 (2006.01) Anaesthetics

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

9 April 2009 PCT application entered the National Phase

  PCT publication WO2008/041075 Priority application(s): WO2008/041075

15 July 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 24 Jun 2010

24 February 2011 Application Accepted

  Published as AU-B-2007303889

23 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007303909-Sulfonamide derivatives as adrenergic agonists and muscarinic antagonists

2007303876-Biological waste treatment plant